Cargando…
The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs
BACKGROUND: Canine babesiosis due to Babesia canis is an endemic disease in many European countries. A vaccine is available in some countries, but it does not prevent the infection and just helps in reducing the gravity of clinical signs. Therefore, the major way to help preventing the disease is by...
Autores principales: | Beugnet, Frederic, Halos, Lenaig, Larsen, Diane, Labuschagné, Michel, Erasmus, Heidi, Fourie, Josephus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078974/ https://www.ncbi.nlm.nih.gov/pubmed/24957215 http://dx.doi.org/10.1186/1756-3305-7-283 |
Ejemplares similares
-
A novel combination of fipronil and permethrin (Frontline Tri-Act®/Frontect®) reduces risk of transmission of Babesia canis by Dermacentor reticulatus and of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs
por: Jongejan, Frans, et al.
Publicado: (2015) -
Early Babesia canis transmission in dogs within 24 h and 8 h of infestation with infected pre-activated male Dermacentor reticulatus ticks
por: Varloud, Marie, et al.
Publicado: (2018) -
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard(®)
por: Liebenberg, Julian, et al.
Publicado: (2017) -
Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei
por: Beugnet, Frédéric, et al.
Publicado: (2016) -
Novel foci of Dermacentor reticulatus ticks infected with Babesia canis and Babesia caballi in the Netherlands and in Belgium
por: Jongejan, Frans, et al.
Publicado: (2015)